A drug that lowers cholesterol might help save hospitalized patients with COVID-19, a new, small Israeli study suggests. Researchers at Hebrew University of Jerusalem noted that COVID causes a big buildup of cholesterol, which results in inflammation in cells. In lab experiments, they found that the cholesterol-lowering drug fenofibrate (TriCor) effectively reduced damage to lung… read on > read on >







